Mechanistic studies of novel glioblastoma therapies involving the natural compound asiatic acid [47] and a retroviral approach using mutant survivin [48] have also reported that z-VAD-FMK could not protect glioblastoma cell death from these various insults. This evidence concerns the gene BIRC5 and glioblastoma.